A detailed history of First Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, First Bank & Trust holds 9,963 shares of AMGN stock, worth $3.11 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
9,963
Previous 11,895 16.24%
Holding current value
$3.11 Million
Previous $3.43 Million 17.31%
% of portfolio
0.61%
Previous 0.83%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$268.87 - $324.56 $519,456 - $627,049
-1,932 Reduced 16.24%
9,963 $2.83 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $367,696 - $414,805
-1,438 Reduced 10.79%
11,895 $3.43 Million
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $496,991 - $617,028
2,273 Added 20.55%
13,333 $3.58 Million
Q2 2023

Jul 12, 2023

BUY
$214.27 - $253.37 $989,927 - $1.17 Million
4,620 Added 71.74%
11,060 $2.46 Million
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $714,851 - $871,283
-3,166 Reduced 32.96%
6,440 $1.56 Million
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $220,326 - $279,951
962 Added 11.13%
9,606 $2.52 Million
Q3 2022

Oct 28, 2022

BUY
$224.46 - $253.15 $241,518 - $272,389
1,076 Added 14.22%
8,644 $1.95 Million
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $104,511 - $116,303
453 Added 6.37%
7,568 $1.84 Million
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $64,246 - $71,073
293 Added 4.29%
7,115 $1.72 Million
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $857,968 - $981,866
4,314 Added 172.01%
6,822 $1.54 Million
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $44,364 - $51,978
209 Added 9.09%
2,508 $533,000
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $25,226 - $27,987
108 Added 4.93%
2,299 $560,000
Q1 2021

Apr 14, 2021

SELL
$221.91 - $258.6 $2,662 - $3,103
-12 Reduced 0.54%
2,191 $545,000
Q4 2020

Jan 27, 2021

BUY
$216.38 - $257.67 $57,124 - $68,024
264 Added 13.62%
2,203 $507,000
Q3 2020

Oct 26, 2020

BUY
$234.65 - $260.95 $1,173 - $1,304
5 Added 0.26%
1,939 $492,000
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $243,108 - $298,327
1,229 Added 174.33%
1,934 $456,000
Q1 2020

Apr 14, 2020

SELL
$182.24 - $241.7 $366,302 - $485,817
-2,010 Reduced 74.03%
705 $143,000
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $506,136 - $650,560
2,675 Added 6687.5%
2,715 $655,000
Q3 2019

Oct 17, 2019

SELL
$174.11 - $208.62 $1,218 - $1,460
-7 Reduced 14.89%
40 $8,000
Q2 2019

Jul 26, 2019

BUY
$166.7 - $195.41 $1,166 - $1,367
7 Added 17.5%
47 $9,000
Q1 2019

Apr 15, 2019

BUY
$180.87 - $203.88 $7,234 - $8,155
40 New
40 $8,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Bank & Trust Portfolio

Follow First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.